Author

Daniel David

Observed names: D. Bem David, D. David

Institution: University of Haiti

Observed institutions: Mayo Clinic, Johns Hopkins University, Hebrew University of Jerusalem, Hadassah Medical Center, University of Haiti, Stallergenes Greer (France)

OpenAlex ID: A5014461544

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

2018 · Pedro Cahn, Juan Sierra Madero, et al. · The Lancet · 390

Characteristics of Patients with Respiratory Allergy in France and Factors Influencing Immunotherapy Prescription: A Prospective Observational Study (Realis)

2011 · M. Migueres, J.-F. Fontaine, et al. · International Journal of Immunopathology and Pharmacology · 53

Long term dual antiretroviral therapy: A real life retrospective countrywide Israeli study

2021 · Daniel David, Eynat Kedem, et al. · PLoS ONE · 2

Osteogenesis Imperfecta Type 3 in a 10-Year-Old Child With Acute Respiratory Distress Syndrome

2022 · Delange Augustin, Delange Hendrick Augustin, et al. · Cureus

S865 Change in Clone Size Does Not Predict Risk of Major Adverse Vascular Events: Results From the International Pnh Registry

2019 · R. Peffault de Latour, A. Kulasekararaj, et al. · HemaSphere

Works count: 5

Citation count: 445

H-index: 2

I10-index: 2